Search Result "GPER"
Multifactorial Regulation of GPER Expression in Cancer Cells and Cardiomyocytes
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2011 Page: 235-242
Author(s): Adele Vivacqua, Rosamaria Lappano, Ernestina Marianna De Francesco, Paola De Marco, Marcello Maggiolini
Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 5 Year: 2012 Page: 531-542
Author(s): R. Lappano,C. Rosano,M. F. Santolla,M. Pupo,E. M. De Francesco,P. De Marco,M. Ponassi,A. Spallarossa,A. Ranise,M. Maggiolini
GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2011 Page: 255-261
Author(s): Matthias R. Meyer, Eric R. Prossnitz, Matthias Barton
GPER and ER: Estrogen Receptors with Distinct Biological Roles in Breast Cancer
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2011 Page: 243-254
Author(s): Edward J. Filardo
(6-Bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (Carbhydraz) Acts as a GPER Agonist in Breast Cancer Cells
Journal: Current Topics in Medicinal Chemistry
Volume: 15 Issue: 11 Year: 2015 Page: 1035-1042
Author(s): Maria Stefania Sinicropi,Rosamaria Lappano,Anna Caruso,Maria Francesca Santolla,Assunta Pisano,Camillo Rosano,Anna Capasso,Antonella Panno,Jean Charles Lancelot,Sylvain Rault,Carmela Saturnino,Marcello Maggiolini
GPER Overexpression in Cervical Cancer Versus Premalignant Lesions: Its Activation Induces Different Forms of Cell Death
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19 Issue: 6 Year: 2019 Page: 783-791
Author(s): Christian D. Hernandez-Silva,Annie Riera-Leal,Pablo C. Ortiz-Lazareno,Luis F. Jave-Suárez,Adrián Ramírez De Arellano,Edgar I. Lopez-Pulido,José G. Macías-Barragan,Margarita Montoya-Buelna,Judith R. Dávila-Rodríguez,Paola Chabay,José F. Muñoz-Valle,Ana L. Pereira-Suárez
Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19 Issue: 6 Year: 2019 Page: 760-771
Author(s): Oscar J. ZacarÃas-Lara,David Méndez-Luna,Gustavo MartÃnez-RuÃz,José R. GarcÃa-Sanchéz,Manuel J. Fragoso-Vázquez,Martiniano Bello,Elvia Becerra-MartÃnez,Juan B. GarcÃa-Vázquez,José Correa-Basurto
Role of Estrogen Receptors and GPR30/GPER in Glucose Homeostasis
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2011 Page: 282-293
Author(s): Ana B. Ropero
Recent Advances in the Rationale Design of GPER Ligands
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 3 Year: 2012 Page: 6199-6206
Author(s): C. Rosano, R. Lappano, M. F. Santolla, M. Ponassi, A. Donadini, M. Maggiolini
Editorial [Hot Topic: GPR30/GPER vs. ERalpha and ERbeta: Why Estrogens Need so Many Receptors (Guest Editor: Marcello Maggiolini)]
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2011 Page: 234-234
Author(s): Marcello Maggiolini